澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

EBR SYSTEMS INC-CDI

0.245

0.000

成交量：192.93萬

成交額：46.79萬

市值：2.07億

市盈率：-1.32

高：0.250

開：0.250

低：0.235

收：0.245

52周最高：1.470

52周最低：0.235

股本：8.45億

流通股本：3,748.74萬

量比：0.93

換手率：5.15%

股息：- -

股息率：- -

每股收益(TTM):-0.186

每股收益(LYR):-0.165

淨資產收益率：-102.51%

總資產收益率：-28.46%

市淨率：2.13

市盈率(LYR):-1.49

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

EBR Systems宣佈計劃於2026年第四季度向FDA提交變更生效（CBE）上市前批准（PMA）補充申請

EBR Systems Inc：網絡猜測源於涉事站點的強制事件報告，並非美國FDA審查

EBR Systems Inc稱現階段無持續擔憂，其他站點商業植入正常進行

EBR Systems Inc 事件：FDA將依據現場信息與公司內部調查結果進行審查

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/EBR.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"EBR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EBR.AU\",,,,,undefined,":{"symbol":"EBR.AU","market":"AU","secType":"STK","nameCN":"EBR SYSTEMS INC-CDI","latestPrice":0.245,"timestamp":1789539120000,"preClose":0.245,"halted":0,"volume":1929332,"delay":0,"changeRate":0,"nameEN":"EBR SYSTEMS INC-CDI","floatShares":37487407,"shares":845410900,"eps":-0.18604756198597897,"marketStatus":"未開盤","change":0,"latestTime":"09-16 16:12:00 AEST","open":0.25,"high":0.25,"low":0.235,"amount":467932,"amplitude":0.061224,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.18604756198597897,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":0,"adr":0,"adrRate":1,"exchange":"ASX","adjPreClose":0.245,"openAndCloseTimeList":[[1789516800000,1789538400000]],"volumeRatio":0.9300501832875689,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"EBR.AU","preClose":0.245,"auctionPrice":0.245,"auctionVolume":26728,"auction":3,"marketStatus":"盘后竞价","timestamp":1789539008148}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EBR.AU\",,,,,undefined,":{"symbol":"EBR.AU","floatShares":37487407,"roa":"-28.46%","roe":"-102.51%","lyrEps":-0.1649,"volumeRatio":0.9300501832875689,"shares":845410900,"dividePrice":0,"high":0.25,"amplitude":0.061224,"preClose":0.245,"low":0.235,"week52Low":0.235,"pbRate":"2.13","psRate":"22.77","week52High":1.47,"institutionHeld":0,"latestPrice":0.245,"eps":-0.18604756198597897,"divideRate":0,"volume":1929332,"delay":0,"ttmEps":-0.18604756198597897,"open":0.25,"prevYearClose":0.895,"prevWeekClose":0.255,"prevMonthClose":0.275,"prevQuarterClose":0.39,"fiveDayClose":0.295,"twentyDayClose":0.275,"sixtyDayClose":0.385,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EBR.AU\",params:#limit:5,,,undefined,":[{"date":"2026-07-30","symbol":"EBR.AU","type":"earning","reportTimeType":"pre","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1785369600000,"name":null,"time":"盤前","dateTimestamp":1785333600000,"actualEps":null},{"date":"2026-04-10","symbol":"EBR.AU","type":"earning","reportTimeType":"pre","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1775779200000,"name":null,"time":"盤前","dateTimestamp":1775743200000,"actualEps":null},{"market":"AU","date":"2026-04-02","symbol":"EBR.AU","defaultRemindTime":1775084400000,"type":"split","dateTimestamp":1775048400000,"forFactor":1,"toFactor":1,"ratio":1},{"date":"2024-11-12","symbol":"EBR.AU","type":"earning","reportTimeType":"pre","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1731366000000,"name":null,"time":"盤前","dateTimestamp":1731330000000,"actualEps":null},{"market":"AU","date":"2024-09-20","symbol":"EBR.AU","defaultRemindTime":1726790400000,"type":"split","dateTimestamp":1726754400000,"forFactor":992429,"toFactor":1000000,"ratio":0.992429}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EBR.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EBR.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1187340625","title":"EBR Systems宣佈計劃於2026年第四季度向FDA提交變更生效（CBE）上市前批准（PMA）補充申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1187340625","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187340625?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 06:38","pubTimestamp":1789511893,"startTime":"0","endTime":"0","summary":"EBR Systems近日披露，该公司已规划好下一步监管路径——计划在2026年第四季度向美国食品药品监督管理局（FDA）递交一份变更生效（CBE）上市前批准（PMA）补充申请。这一举措标志着公司在推进其产品审批流程方面迈出了关键一步。值得注意的是，CBE补充申请通常用于在已批准产品的制造、标签或规格等方面实施某些变更，而无需事先获得FDA的明确批准即可生效，但须符合特定条件。EBR Systems此番动作，显然意在加快相关调整的实施节奏，以更好地顺应市场或生产需求的变化。该计划若如期落地，将进一步考验公司在合规框架下的执行效率与应变能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBR.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114786525","title":"EBR Systems Inc：網絡猜測源於涉事站點的強制事件報告，並非美國FDA審查","url":"https://stock-news.laohu8.com/highlight/detail?id=1114786525","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114786525?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 07:13","pubTimestamp":1785453206,"startTime":"0","endTime":"0","summary":"EBR Systems Inc 指出，近日网络上的种种猜测，实则是基于一家涉事站点所提交的强制性事件报告。这一报告，并非美国食品药品监督管理局（FDA）进行的正式审查。公司明确表示，流传的揣测与事实存在偏差，请投资者注意甄别信息源。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","EBR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167781876","title":"EBR Systems Inc稱現階段無持續擔憂，其他站點商業植入正常進行","url":"https://stock-news.laohu8.com/highlight/detail?id=1167781876","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167781876?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 07:13","pubTimestamp":1785453203,"startTime":"0","endTime":"0","summary":"EBR Systems Inc声明，现阶段并不存在持续性的担忧。在其他站点，商业植入工作正按常规流程持续推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","EBR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146596439","title":"EBR Systems Inc 事件：FDA將依據現場信息與公司內部調查結果進行審查","url":"https://stock-news.laohu8.com/highlight/detail?id=1146596439","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146596439?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 07:13","pubTimestamp":1785453189,"startTime":"0","endTime":"0","summary":"EBR Systems Inc 宣布，美国食品药品监督管理局（FDA）将审阅相关事件。此次审查将基于两个关键信息来源：由现场提供的数据，以及该公司刚刚结束的内部调查所取得的结果。这一过程意味着，监管机构将综合考量多方信息，以评估情况全貌。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBR.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/EBR.AU\",params:#limit:6,delay:true,,,undefined,":[]}}